| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.09 | 0.06 |